Please use this identifier to cite or link to this item:
https://repositorio.ufba.br/handle/ri/13607
metadata.dc.type: | Artigo de Periódico |
Title: | Recombinant Leishmania Antigens for Serodiagnosis of Visceral Leishmaniasis |
Other Titles: | Clinical and Vaccine Immunology |
Authors: | Passos, S. Carvalho, Lain Carlos Pontes de Orge, G. Jerônimo, S. M. Bezerra, G. F. Soto, Manuel Alonso, Carlos Carvalho Filho, Edgar Marcelino de |
metadata.dc.creator: | Passos, S. Carvalho, Lain Carlos Pontes de Orge, G. Jerônimo, S. M. Bezerra, G. F. Soto, Manuel Alonso, Carlos Carvalho Filho, Edgar Marcelino de |
Abstract: | Serological tests with crude or recombinant Leishmania antigens are important tools for the diagnosis of leishmania infection. However, these tests are not markers of active visceral leishmaniasis (VL), since antibodies to these markers are often observed in individuals with subclinical L. chagasi infection and they do not fall shortly after therapy. In this study, levels of immunoglobulin G (IgG) against three recombinant Leishmania antigens (rH2A, KMP11, and the “Q” protein) were evaluated in sera from individuals with subclinical L. chagasi infection and in patients with VL pre- and posttherapy. The sensitivity of the serological test for diagnosis of VL was 100% with all three antigens. The titers of IgG fell significantly after therapy. While most of the individuals with subclinical L. chagasi infection had antibodies to rH2A and the “Q” protein, only 1 out of 15 individuals had antibodies to KMP11. These data indicate that KMP11 may be used to discriminate L. chagasi infection from active VL and may serve as a marker of response to therapy. |
metadata.dc.rights: | Acesso Aberto |
URI: | http://repositorio.ufba.br/ri/handle/ri/13607 |
Issue Date: | 2005 |
Appears in Collections: | Artigo Publicado em Periódico (Faculdade de Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
S. Passos.pdf | 155,26 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.